LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Durect Corp

Geschlossen

0.63 3.28

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.62

Max

0.63

Schlüsselkennzahlen

By Trading Economics

Angestellte

21

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+971.43% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

19. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-4.6M

19M

Vorheriger Eröffnungskurs

-2.65

Vorheriger Schlusskurs

0.63

Durect Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

16. Mai 2025, 19:39 UTC

Wichtige Markttreiber

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

17. Mai 2025, 09:30 UTC

Top News
Ergebnisse

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17. Mai 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Mai 2025, 08:20 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

16. Mai 2025, 23:18 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16. Mai 2025, 22:30 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- Update

16. Mai 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16. Mai 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. Mai 2025, 21:54 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- WSJ

16. Mai 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16. Mai 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16. Mai 2025, 21:17 UTC

Top News

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16. Mai 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16. Mai 2025, 20:55 UTC

Akquisitionen, Fusionen, Übernahmen

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. Mai 2025, 20:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

16. Mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. Mai 2025, 20:37 UTC

Top News

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16. Mai 2025, 20:33 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16. Mai 2025, 20:30 UTC

Akquisitionen, Fusionen, Übernahmen

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16. Mai 2025, 20:18 UTC

Top News

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16. Mai 2025, 20:16 UTC

Top News

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16. Mai 2025, 20:15 UTC

Ergebnisse

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16. Mai 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Henry Schein: William K. Daniel Joins Board

16. Mai 2025, 20:10 UTC

Akquisitionen, Fusionen, Übernahmen

Henry Schein: Strategic Investment by KKR Completed

16. Mai 2025, 20:05 UTC

Akquisitionen, Fusionen, Übernahmen

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. Mai 2025, 19:38 UTC

Market Talk

Oil Futures Post Second Straight Weekly Gain -- Market Talk

16. Mai 2025, 19:07 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

16. Mai 2025, 18:51 UTC

Top News

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

16. Mai 2025, 18:41 UTC

Akquisitionen, Fusionen, Übernahmen

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. Mai 2025, 18:37 UTC

Market Talk

Gold Futures End Week on Negative Note -- Market Talk

Peer-Vergleich

Kursveränderung

Durect Corp Prognose

Kursziel

By TipRanks

971.43% Vorteil

12-Monats-Prognose

Durchschnitt 6.75 USD  971.43%

Hoch 8.5 USD

Tief 5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Durect Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Finanzen

$

Über Durect Corp

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.